Ryan Martins

Ryan Martins

Finansdirektör/CFO på 89BIO, INC.
49 år
Health Technology
Finance
Consumer Services

Profil

Ryan Stephen Martins is currently Chief Financial Officer at 89bio, Inc., a position held since 2019.
Formerly, Mr. Martins was Chief Financial Officer at Revolution Medicines, Inc. in 2018; VP-Corporate Strategy & Investor Relations at Ultragenyx Pharmaceutical, Inc. from 2015 to 2018; Senior Biotechnology Analyst at Jefferies LLC from 2014 to 2015; Senior Biotechnology Analyst at FM Partners Holdings LLC from 2013 to 2014; Vice President at Barclays Capital, Inc. from 2008 to 2011; Associate at Lehman Brothers, Inc. from 2006 to 2008; Principal at Chiron Corp.
in 2006.
Education includes degrees from Virginia Polytechnic Institute & State University (graduate, 2001), the University of Mumbai (undergraduate and graduate), Haas School of Business (MBA), and St. Xavier's College (undergraduate).

Aktiva positioner av Ryan Martins

FöretagPositionStart
89BIO, INC. Finansdirektör/CFO 2019-07-01

Tidigare kända positioner av Ryan Martins

FöretagPositionSlut
REVOLUTION MEDICINES, INC. Finansdirektör/CFO 2018-10-01
ULTRAGENYX PHARMACEUTICAL INC. Investor Relations Kontakt 2018-03-01
Analyst-Equity 2015-07-01
Analyst-Equity 2014-01-31
Analyst-Equity -
Se detaljerna i Ryan Martinss erfarenhet

Ryan Martinss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

94

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Finance

Health Technology

Finance

Finance

Finance

Consumer Services

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Ryan Martins